Ipg Photonics Corp SEC Filings

Insider sales under a pre-established plan reduced the Trust's stake in IPG Photonics. The Valentin Gapontsev Trust I reported three separate dispositions of common stock on September 15-16, 2025, totaling 66,500 shares sold under a Rule 10b5-1 trading plan adopted June 13, 2025. The transactions had weighted-average sale prices of $80.54, $81.15 and $80.67 across the respective blocks; the Form 4 shows the Trust's beneficial ownership declining from 7,087,705 shares after the first block to 7,059,099 shares after the final reported sale. The filing is signed by an attorney-in-fact and notes the Reporting Person will provide per-price breakdowns on request.

Insider transactions at IPG Photonics (IPGP): This Form 4 reports that Dr. Igor Samartsev and his spouse, Natalia Pavlova, adjusted their beneficial ownership through multiple transfers to family trusts in late August and early September 2025. On August 29, 2025 Dr. Samartsev contributed 121,002 shares to "Trust-I May 2017" and 121,951 shares to "Grantor Retained Annuity Trust II September 2025." On September 2–3, 2025 additional transfers moved 122,225 and 24,590 shares among trusts. The filing also reports a disposition of 6,234 shares. The changes reflect reallocation of existing holdings among direct and indirect ownership vehicles, with Ms. Pavlova noted as an indirect beneficiary as spouse.

Insider sales by IPG Photonics officer recorded on Form 4. Trevor Ness, SVP, Sales & Strategic Bus Dev, sold a total of 1,678 shares on 08/27/2025 under a Rule 10b5-1 trading plan adopted May 28, 2025. The sales were reported at weighted average prices of $82.69 (1,004 shares) and $83.31 (674 shares), and the reporting lines show beneficial ownership of 42,917 and 42,243 shares following those transactions. The Form 4 was signed by an attorney-in-fact on 08/28/2025. The filing discloses price ranges and offers to provide per-price sale details on request.

IPG Photonics (IPGP) Form 144 filing: The filer notified a proposed sale of 6,715 shares of common stock through Stifel Nicolaus & Company, listing an aggregate market value of $556,951 and reporting 42,219,918 shares outstanding. The approximate date of sale is 08/27/2025. The shares were acquired as Restricted Stock Units on 03/01/2021 from the issuer, with payment noted as cash on the acquisition date. The filer reports no securities sold in the past three months for the account. The notice includes the filer’s representation that they are not aware of any undisclosed material adverse information.

Bucher Paulus, SVP Global Operations at IPG Photonics (IPGP), was granted 4,185 restricted stock units (RSUs) reported as an acquisition at a price of $0, and is shown as the direct beneficial owner of 4,185 shares following the transaction. The award is recorded on the Form 4 as an increase in beneficial ownership.

The RSUs vest in three annual installments: 33% on August 8, 2026, 33% on August 8, 2027, and 34% on August 8, 2028, creating staged delivery of the shares over three years.

Desmond Jeanmarie F., a director of IPG Photonics Corporation (IPGP), reported the sale of 1,360 shares of the issuer's common stock on 08/08/2025. The filing states the transactions were sales at prices ranging from $76.02 to $76.51 per share with a weighted average price of $76.24. After the reported sale, the reporting person beneficially owned 9,740 shares. The form is signed on behalf of the reporting person by attorney-in-fact Adam N. King on 08/08/2025. The filer lists an address at C/O IPG Photonics Corporation, 377 Simarano Drive, Marlborough, MA 01752. The filer offers to provide, upon request, the breakdown of shares sold at each separate price.

IPG Photonics filed a Form 144 reporting a proposed sale of 1,360 shares of common stock through Stifel Nicolaus & Company Inc on 08/08/2025, with an aggregate market value of $103,684. The filing lists 42,219,918 shares outstanding. The securities were acquired as restricted stock units from the issuer on 02/18/2022 (80 shares) and 05/23/2023 (1,280 shares) and are identified as equity compensation. The filer reports no securities sold in the past three months and attests they do not possess undisclosed material information.